483
Fresenius Kabi USA, LLCFresenius Kabi USA, LLC – FDA 483, Aug 12, 2019
Record Details
Fresenius Kabi USA, LLC, a sterile drug manufacturer in Grand Island, NY, received a Form 483 with two observations. The firm failed to establish adequate control procedures for manufacturing processes, specifically regarding the evaluation of decontamination effects on drug product compatibility. Additionally, the quality control unit did not perform timely reviews of analytical data, leading to issues with impurity results for Vancomycin products.
View Company Profile
ID · 90344142-2ce1-4a03-96d2-df8dfafa023e
Other documents for Fresenius Kabi USA, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.